04 Jan Stem Cell Therapy for Autism in Australia
According to the Autism Association of Western Australia, approximately 1 in 100 people in the country have Autism. Ever since the diagnosis of Autism has been altered to include Autism Spectrum Disorder (ASD), the incidence is most likely 1 in 65 or so like it is in the USA.
Patients with ASD show a wide range of variations in symptoms, condition severity, and functional disability (Geschwind, 2009). Scientists have not yet been able to determine the exact cause leading to ASD.

ASD may be divided into two main symptom categories: The first one is reduced social interaction and the second one is repetitive behaviors, curiosities, and aggressive actions. ASD can sometimes be detected at eighteen months or younger.
Stem cell therapy for autism in Australia is now available with R3 Stem Cell. While providing the stem cells in Australia is not allowed, R3 offers the ASD treatment with stem cells in Manila Philippines at its contemporary, fully equipped facility. Children as young as 2 years of age are treated.

Traditional treatments for autism have, by and large, been exceptionally disappointing. Speech and behavioral therapies may be slightly helpful along with off label usage of medication such as psychotropic drugs.
Alternative therapies such as hyperbaric oxygen have shown promise, with stem cell therapy emerging as a breakthrough for improving children with ASD. The key point here is that to date, the conventional and alternative therapies that exist are typically just not satisfactory to parents. R3 receives many calls a day from parents around the world who have tried traditional therapies with unsatisfactory results.
Stem cell therapies for autism around the world have focused either on autologous or allogeneic biologics. Autologous refers to using the patient’s own bone marrow or adipose (fat ) tissue. There have been no published clinical trial results for adipose stem cells for ASD to date.
When it comes to using a patient’s own bone marrow, there was a 2023 study published in Regenerative Medicine by Sharma et al. The cells were delivered intrathecally (into the spinal cord), with no significant adverse events being seen (temporary nausea/vomiting were reported).
After six months of follow up, there was improved concentration, stable sleep patterns, proper eye contact, great social interaction and improved memory were recorded.
Impressive results have been seen with clinical trials evaluating umbilical cord stem cells for ASD. Duke University completed multiple studies evaluating umbilical cord blood for ASD patients between 2 and 6 years of age. The dose of total nucleated cells for patients was between 1-5 x 107 cells/kilogram.
The researchers noted UCB to be safe for administration, either autologous or allogenic. Significant improvement was observed in the communication activities involving toys and employing focus.

An elegant study was performed a few years ago in Shandong China in 37 autistic subjects. The children received a combination of umbilical cord blood along with mesenchymal stem cells. The intervention group was compared versus a control group who only received traditional therapies.
The significant changes observed included improved social and behavioral withdrawals, enhanced eye contact, less emotional and aggressive response, adaptability, and less hyperactivation and unstable speech patterns. At 24-week follow-up, the results were compared with the control group, and considerably higher improvements were seen in the combination group.
Based on the incredible outcomes with umbilical cord stem cells globally, R3 Stem Cell began performing stem cell therapies for ASD over 5 years ago. With over 45 Centers in 6 countries, R3 Stem Cell is now the global leader in regenerative therapies for both adults and children.
For Autistic children in Australia, R3 performs the umbilical cord stem cell therapies in Manila Philippines. The clinic is contemporary, well equipped, and the procedures are performed by highly experienced doctors.
R3 uses very high numbers of cells for ASD children, as it is critical to make sure that enough stem cells are administered for best results. Along with the high amounts of stem cells, R3 Stem Cell also provides exosomes to boost the results.

What are exosomes?
Exosomes are acellular, nano-sized vesicles that are byproducts of cells. R3 uses exosomes derived from umbilical cord stem cells. They are great at cell to cell communication, along with reducing inflammation.
The combination of umbilical cord stem cells and exosomes has shown amazing satisfaction for families of children with ASD. Over 85% of families are happy with the outcomes and say they would do it again.
In fact, approximately 2/3 of families end up having the procedure repeated! This allows the ASD children to continue to improve, with results that typically include:
- Less hyperactivity.
- Improved communication (verbal and/or nonverbal).
- Better attention span and eye contact.
- Less aggressiveness towards family and friends.
The procedures themselves, in line with the published studies, have been very safe. Side effects may include low grade fever, nausea, dizziness, chills. These are temporary and minor to moderate.
When it comes to the biologics, R3 Stem Cell’s quality assurance is second to none. The lab uses quality assurance that exceeds FDA standards. The umbilical cord tissue comes from consenting donors after a scheduled c-section.
The donor completes a 210 question form, and a Medical Director reviews the answers for safety. The processed tissue has samples sent to a third party for testing to make sure the biologics are free of communicable diseases or contaminants. Only if all the testing comes back negative is the product ok to use on patients.
R3 Stem Cell has not experienced a deep infection or a rejection in the recipients. In fact, the stem cells are called, “immunologically privileged”, as they do not have MHC-2 markers. Therefore, they do not spark up a rejection reaction.
R3 Stem Cell offers free consultations for families to see if their ASD child is a candidate. Along with safety and effectiveness that are unparalleled globally, R3 takes a lot of pride in its pricing model. In addition, R3 Stem Cell has written a Guide to Stem Cell Therapy for Autism. Click below to get a free copy!

Children with ASD need a lot of cells for the best outcomes. Clinics in Panama and China charge very high amounts per treatment. How, then, are patients supposed to get repeat treatments without families going into big time debt?
With R3 Stem Cell, that’s not necessary! Our pricing is much less than half of these high priced stem cell clinics. See for yourself, call us today to set up the free consultation and visit r3stemcell.com/Australia for the number and more information!
No Comments